Pacific Capital Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $283K | Sell |
2,211
-17,413
| -89% | -$2.23M | 0.05% | 67 |
|
2025
Q1 | $2.51M | Sell |
19,624
-32,624
| -62% | -$4.17M | 0.43% | 26 |
|
2024
Q4 | $6.91M | Sell |
52,248
-11,136
| -18% | -$1.47M | 1.15% | 15 |
|
2024
Q3 | $9.23M | Sell |
63,384
-717
| -1% | -$104K | 1.55% | 13 |
|
2024
Q2 | $8.8M | Buy |
64,101
+13,627
| +27% | +$1.87M | 1.61% | 13 |
|
2024
Q1 | $6.93M | Sell |
50,474
-1,270
| -2% | -$174K | 1.63% | 14 |
|
2023
Q4 | $7.03M | Sell |
51,744
-11,951
| -19% | -$1.62M | 1.78% | 13 |
|
2023
Q3 | $7.79M | Sell |
63,695
-6,121
| -9% | -$749K | 2.18% | 11 |
|
2023
Q2 | $8.86M | Sell |
69,816
-1,320
| -2% | -$168K | 2.25% | 13 |
|
2023
Q1 | $9.19M | Buy |
71,136
+1,027
| +1% | +$133K | 2.36% | 13 |
|
2022
Q4 | $9.2M | Buy |
70,109
+4,265
| +6% | +$560K | 2.38% | 13 |
|
2022
Q3 | $7.7M | Buy |
65,844
+5,409
| +9% | +$633K | 2.1% | 14 |
|
2022
Q2 | $7.11M | Buy |
+60,435
| New | +$7.11M | 1.97% | 14 |
|